MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin e2 synthase-2

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5102-5109

  Matysiak, Mariola ^a   Fortak Michalska, Maria ^a   Szymanska, Bozena ^a   Orlowski, Wojciech ^a   Jurewicz, Anna ^a   Selmaj, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 146A; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2 SYNTHASE 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN E2 SYNTHASE 2 GENE; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICRORNAS; NEURAL STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84877816217     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202397     Document Type: Article

References (47)

1. Frohman, E. M., M. K. Racke, and C. S. Raine. 2006. Multiple sclerosis -the plaque and its pathogenesis. N. Engl. J. Med. 354: 942-955.
2. Lassmann, H. 2005. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. J. Neurol. Sci. 233: 83-86. (Pubitemid 40804820)
3. Pluchino, S., and G. Martino. 2005. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J. Neurol. Sci. 233: 117-119. (Pubitemid 40804826)
4. Karussis, D., and I. Kassis. 2008. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin. Neurol. Neurosurg. 110: 889-896.
5. Alhadlaq, A., and J. J. Mao. 2004. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 13: 436-448. (Pubitemid 39223294)
6. Seshi, B., S. Kumar, and D. Sellers. 2000. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol. Dis. 26: 234-246.
7. Arthur, A., A. Zannettino, and S. Gronthos. 2009. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218: 237-245.
8. Muruganandan, S., A. A. Roman, and C. J. Sinal. 2009. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell. Mol. Life Sci. 66: 236-253.
9. Petersen, B. E., W. C. Bowen, K. D. Patrene, W. M. Mars, A. K. Sullivan, N. Murase, S. S. Boggs, J. S. Greenberger, and J. P. Goff. 1999. Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-1170. (Pubitemid 29288406)
10. Brazelton, T. R., F. M. Rossi, G. I. Keshet, and H. M. Blau. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775-1779. (Pubitemid 32004810)
11. Kopen, G. C., D. J. Prockop, and D. G. Phinney. 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 96: 10711-10716. (Pubitemid 29442209)
12. Yoo, S.W., S. S. Kim, S. Y. Lee, H. S. Lee, H. S. Kim, Y. D. Lee, and H. Suh-Kim. 2008. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 40: 387-397.
13. Ramasamy, R., C. K. Tong, H. F. Seow, S. Vidyadaran, and F. Dazzi. 2008. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell. Immunol. 251: 131-136.
14. Tabera, S., J. A. Pérez-Simón, M. Díez-Campelo, L. I. Sánchez-Abarca, B. Blanco, A. López, A. Benito, E. Ocio, F. M. Sánchez-Guijo, C. Canizo, and J. F. San Miguel. 2008. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93: 1301-1309.
15. English, K., F. P. Barry, and B. P. Mahon. 2008. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett. 115: 50-58. (Pubitemid 350298590)
16. Nasef, A., A. Chapel, C. Mazurier, S. Bouchet, M. Lopez, N. Mathieu, L. Sensebé, Y. Zhang, N. C. Gorin, D. Thierry, and L. Fouillard. 2007. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of Tlymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr. 13: 217-226. (Pubitemid 47024153)
17. Parekkadan, B., D. van Poll, Z. Megeed, N. Kobayashi, A. W. Tilles, F. Berthiaume, and M. L. Yarmush. 2007. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem. Biophys. Res. Commun. 363: 247-252. (Pubitemid 47484321)
18. Dazzi, F., and F. M. Marelli-Berg. 2008. Mesenchymal stem cells for graft-versushost disease: close encounters with T cells. Eur. J. Immunol. 38: 1479-1482.
19. Aggarwal, S., and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
20. Jarvinen, L., L. Badri, S. Wettlaufer, T. Ohtsuka, T. J. Standiford, G. B. Toews, D. J. Pinsky, M. Peters-Golden, and V. N. Lama. 2008. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J. Immunol. 181: 4389-4396.
21. Yanez, R., A. Oviedo, M. Aldea, J. A. Bueren, and M. L. Lamana. 2010. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp. Cell Res. 316: 3109-3123.
22. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
23. Lagos-Quintana, M., R. Rauhut, W. Lendeckel, and T. Tuschl. 2001. Identification of novel genes coding for small expressed RNAs. Science 294: 853-858. (Pubitemid 33032103)
24. Yekta, S., I. H. Shih, and D. P. Bartel. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596. (Pubitemid 38541919)
25. Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862. (Pubitemid 24014543)
26. Wu, L., J. Fan, and J. G. Belasco. 2006. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA 103: 4034-4039.
27. Lakshmipathy, U., and R. P. Hart. 2008. Concise review: microRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26: 356-363. (Pubitemid 351413595)
28. Xu, N., T. Papagiannakopoulos, G. Pan, J. A. Thomson, and K. S. Kosik. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658.
29. Baddoo, M., K. Hill, R. Wilkinson, D. Gaupp, C. Hughes, G. C. Kopen, and D. G. Phinney. 2003. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem. 89: 1235-1249. (Pubitemid 36959389)
30. Holmes, C., and W. L. Stanford. 2007. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25: 1339-1347. (Pubitemid 47106000)
31. Grajales, L., J. García, K. Banach, and D. L. Geenen. 2010. Delayed enrichment of mesenchymal cells promotes cardiac lineage and calcium transient development. J. Mol. Cell. Cardiol. 48: 735-745.
32. Phinney, D. G. 2008. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol. Biol. 449: 171-186.
33. Castoldi, M., S. Schmidt, V. Benes, M. Noerholm, A. E. Kulozik, M. W. Hentze, and M. U. Muckenthaler. 2006. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 12: 913-920.
34. Matysiak, M., W. Orlowski, M. Fortak-Michalska, A. Jurewicz, and K. Selmaj. 2011. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J. Neuroimmunol. 233: 106-111.
35. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868. (Pubitemid 29003722)
36. Griffiths-Jones, S. 2006. miRBase: the microRNA sequence database. Methods Mol. Biol. 342: 129-138.
37. Grimson, A., K. K. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27: 91-105. (Pubitemid 46991392)
38. Friedman, R. C., K. K. Farh, C. B. Burge, and D. P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19: 92-105.
39. Betel D., M. Wilson, A. Gabow, D. Marks, and C. Sander. 2008. microRNA target predictions: the microRNA.org resource: targets and expression. Nucleic Acids Res. 36(Database Issue): D149-D153. (Pubitemid 351149712)
40. Matysiak, M., M. Stasiołek, W. Orłowski, A. Jurewicz, S. Janczar, C. S. Raine, and K. Selmaj. 2008. Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism. J. Neuroimmunol. 193: 12-23.
41. Volinia, S., G. A. Calin, C. G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103: 2257-2261. (Pubitemid 43271657)
42. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486. (Pubitemid 44267285)
43. Nakasa, T., S. Miyaki, A. Okubo, M. Hashimoto, K. Nishida, M. Ochi, and H. Asahara. 2008. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 58: 1284-1292. (Pubitemid 351705917)
44. Tanikawa, N., Y. Ohmiya, H. Ohkubo, K. Hashimoto, K. Kangawa, M. Kojima, S. Ito, and K. Watanabe. 2002. Identification and characterization of a novel type of membrane-Associated prostaglandin E synthase. Biochem. Biophys. Res. Commun. 291: 884-889. (Pubitemid 34694357)
45. Tanioka, T., Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo. 2000. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275: 32775-32782.
46. Murakami, M., K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, and I. Kudo. 2003. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278: 37937-37947. (Pubitemid 37175324)
47. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane-Associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275: 32783-32792.